Tuning Peptide-Based Nanofibers for Achieving Selective Doxorubicin Delivery in Triple-Negative Breast Cancer
Rosa Bellavita,Marialuisa Piccolo,Linda Leone,Maria Grazia Ferraro,Principia Dardano,Luca De Stefano,Flavia Nastri,Carlo Irace,Annarita Falanga,Stefania Galdiero
DOI: https://doi.org/10.2147/ijn.s453958
IF: 7.033
2024-06-19
International Journal of Nanomedicine
Abstract:Rosa Bellavita, 1, &ast Marialuisa Piccolo, 1, &ast Linda Leone, 2 Maria Grazia Ferraro, 1, 3 Principia Dardano, 4 Luca De Stefano, 4 Flavia Nastri, 2 Carlo Irace, 1 Annarita Falanga, 5 Stefania Galdiero 1, &ast 1 Department of Pharmacy, School of Medicine, University of Naples 'Federico II', Napoli, Italy; 2 Department of Chemical Sciences, University of Napoli "Federico II", Naples, Italy; 3 School of Infection and Immunity, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK; 4 Institute of Applied Sciences and Intelligent Systems, Consiglio Nazionale delle Ricerche, Naples, Italy; 5 Department of Agricultural Science, University of Naples "Federico II", Portici, Italy &astThese authors contributed equally to this work Correspondence: Stefania Galdiero, Email Introduction: The design of delivery tools that efficiently transport drugs into cells remains a major challenge in drug development for most pathological conditions. Triple-negative breast cancer (TNBC) is a very aggressive subtype of breast cancer with poor prognosis and limited effective therapeutic options. Purpose: In TNBC treatment, chemotherapy remains the milestone, and doxorubicin (Dox) represents the first-line systemic treatment; however, its non-selective distribution causes a cascade of side effects. To address these problems, we developed a delivery platform based on the self-assembly of amphiphilic peptides carrying several moieties on their surfaces, aimed at targeting, enhancing penetration, and therapy. Methods: Through a single-step self-assembly process, we used amphiphilic peptides to obtain nanofibers decorated on their surfaces with the selected moieties. The surface of the nanofiber was decorated with a cell-penetrating peptide (gH625), an EGFR-targeting peptide (P22), and Dox bound to the cleavage sequence selectively recognized and cleaved by MMP-9 to obtain on-demand drug release. Detailed physicochemical and cellular analyses were performed. Results: The obtained nanofiber (NF-Dox) had a length of 250 nm and a diameter of 10 nm, and it was stable under dilution, ionic strength, and different pH environments. The biological results showed that the presence of gH625 favored the complete internalization of NF-Dox after 1h in MDA-MB 231 cells, mainly through a translocation mechanism. Interestingly, we observed the absence of toxicity of the carrier (NF) on both healthy cells such as HaCaT and TNBC cancer lines, while a similar antiproliferative effect was observed on TNBC cells after the treatment with the free-Dox at 50 μM and NF-Dox carrying 7.5 μM of Dox. Discussion: We envision that this platform is extremely versatile and can be used to efficiently carry and deliver diverse moieties. The knowledge acquired from this study will provide important guidelines for applications in basic research and biomedicine. Keywords: self-assembling peptides, triple negative breast cancer, nanofiber, on-demand strategy, doxorubicin Graphical Advances in nanotechnology reveal its massive power in the development of delivery platforms considered formidable instruments for the storage and transport of drugs in the treatment of many pathologies. 1,2 Depending on their size, morphology and chemical properties, nanoplatforms provide an extensive and versatile portfolio of biological roles, including targeting specificity, controlled drug release, administration of a reduced amount of the drug, ability to cross a range of biological barriers, as well as a reduction or bypassing of drug resistance phenomenon and reduction of systemic toxicity. 3,4 The development of nanocarriers loaded with a combination of drugs and other moieties promotes a timely and spatially controlled co-delivery of specific amounts of different bioactive compounds, aimed to activate synergistic effects via different pathways thereby increasing their individual efficacy and enhancing drug diffusion and accumulation. 4,5 In recent years, peptide-based nano-assemblies have shown various advantageous facets in drug delivery, such as tunable design, biocompatibility, bifunctionalities, easy synthesis, possibility to exploit on demand strategies and low toxicity compared to other non-biological materials as they are hydrolyzed into amino acids in the body and utilized by surrounding tissues. 6,7 Self-assembly is a relatively simple phenomenon in which peptides spontaneously arrange and form structurally distinct and stabilized nanostructures via intermolecular non-covale -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology